Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Norton

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
British Paramedic Journal|October 24, 2025
The impact of drone delivery of an automated external defibrillator: a simulation feasibility studyOwen Finney, Kate Snowdon, Sara Lomzynska, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 1, 2012
Evaluation of myocardial infarction and coronary artery disease in subjects taking lopinavir/ritonavir: a study using clinical trial and pharmacovigilance databasesBarbara Da Silva, Jean Tschampa, Jörg Beron, et al.
Antiviral Therapy|August 5, 2008
Effect of lopinavir/ritonavir monotherapy on quality of life and self-reported symptoms among antiretroviral-naive patients: results of the MONARK trialBruno Spire, Fabienne Marcellin, Isabelle Cohen-Codar, et al.
AIDS Research and Human Retroviruses|June 27, 2012
Lopinavir/ritonavir combined with raltegravir or tenofovir/emtricitabine in antiretroviral-naive subjects: 96-week results of the PROGRESS studyJacques Reynes, Roger Trinh, Federico Pulido, et al.
HIV Clinical Trials|February 6, 2010
Monotherapy with Lopinavir/Ritonavir as maintenance after HIV-1 viral suppression: results of a 96-week randomized, controlled, open-label, pilot trial (KalMo study)Estevão P Nunes, Marilia Santini de Oliveira, Monica Merçon, et al.
AIDS Care|July 15, 2015
Barriers to access to care reported by women living with HIV across 27 countriesMargaret Johnson, Anna Samarina, He Xi, et al.
Bjpsych Open|May 22, 2026
Revisiting suicide prevention in later life: mixed-methods study protocolM Isabela Troya, Paul Corcoran, Derek Chambers, et al.
AIDS (London, England)|December 22, 2007
Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIVFederico Pulido, José R Arribas, Rafael Delgado, et al.
The Lancet. Infectious Diseases|May 3, 2014
Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trialPedro Cahn, Jaime Andrade-Villanueva, José R Arribas, et al.
AIDS (London, England)|January 16, 2008
Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patientsJean-François Delfraissy, Philippe Flandre, Constance Delaugerre, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
British Paramedic Journal|October 24, 2025
The impact of drone delivery of an automated external defibrillator: a simulation feasibility studyOwen Finney, Kate Snowdon, Sara Lomzynska, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 1, 2012
Evaluation of myocardial infarction and coronary artery disease in subjects taking lopinavir/ritonavir: a study using clinical trial and pharmacovigilance databasesBarbara Da Silva, Jean Tschampa, Jörg Beron, et al.
Antiviral Therapy|August 5, 2008
Effect of lopinavir/ritonavir monotherapy on quality of life and self-reported symptoms among antiretroviral-naive patients: results of the MONARK trialBruno Spire, Fabienne Marcellin, Isabelle Cohen-Codar, et al.
AIDS Research and Human Retroviruses|June 27, 2012
Lopinavir/ritonavir combined with raltegravir or tenofovir/emtricitabine in antiretroviral-naive subjects: 96-week results of the PROGRESS studyJacques Reynes, Roger Trinh, Federico Pulido, et al.
HIV Clinical Trials|February 6, 2010
Monotherapy with Lopinavir/Ritonavir as maintenance after HIV-1 viral suppression: results of a 96-week randomized, controlled, open-label, pilot trial (KalMo study)Estevão P Nunes, Marilia Santini de Oliveira, Monica Merçon, et al.
AIDS Care|July 15, 2015
Barriers to access to care reported by women living with HIV across 27 countriesMargaret Johnson, Anna Samarina, He Xi, et al.
Bjpsych Open|May 22, 2026
Revisiting suicide prevention in later life: mixed-methods study protocolM Isabela Troya, Paul Corcoran, Derek Chambers, et al.
AIDS (London, England)|December 22, 2007
Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIVFederico Pulido, José R Arribas, Rafael Delgado, et al.
The Lancet. Infectious Diseases|May 3, 2014
Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trialPedro Cahn, Jaime Andrade-Villanueva, José R Arribas, et al.
AIDS (London, England)|January 16, 2008
Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patientsJean-François Delfraissy, Philippe Flandre, Constance Delaugerre, et al.
Pageof 6